Complex structural and functional changes occur in the arterial system with advancing age. The aged artery is characterized by changes in microRNA expression patterns, autophagy, smooth muscle cell migration and proliferation, and arterial calcification with progressively increased mechanical vessel rigidity and stiffness. With age the vascular smooth muscle cells modify their phenotype from contractile to 'synthetic' determining the development of intimal thickening as early as the second decade of life as an adaptive response to forces acting on the arterial wall. The increased permeability observed in intimal thickening could represent the substrate on which low-level atherosclerotic stimuli can promote the development of advanced atherosclerotic lesions. In elderly patients the atherosclerotic plaques tend to be larger with increased vascular stenosis. In these plaques there is a progressive accumulation of both lipids and collagen and a decrease of inflammation. Similarly the plaques from elderly patients show more calcification as compared with those from younger patients. The coronary artery calcium score is a well-established marker of adverse cardiovascular outcomes. The presence of diffuse calcification in a severely stenotic segment probably induces changes in mechanical properties and shear stress of the arterial wall favouring the rupture of a vulnerable lesion in a less stenotic adjacent segment. Oxidative stress and inflammation appear to be the two primary pathological mechanisms of ageingrelated endothelial dysfunction even in the absence of clinical disease. Arterial ageing is no longer considered an inexorable process. Only a better understanding of the link between ageing and vascular dysfunction can lead to significant advances in both preventative and therapeutic treatments with the aim that in the future vascular ageing may be halted or even reversed.
determine various structural and physiological changes of the arterial wall that predispose it to atherosclerosis. In particular, inversion of the elastin/collagen ratio [21] [22] [23] [24] [25] and the nonenzymatic glycosylation of some proteins present in the arterial wall, such as collagen, capable of crosslinking adjacent proteins [26] increase the mechanical vessel rigidity and stiffness. The reduction in elasticity and distensibility of the arterial wall determine a reduction in compliance leading to increased systolic and decreased diastolic blood pressure. Ageing is also accompanied by an increase in thickness and a decrease in the cellularity of the tunica media [27] (see Fig. 2 ). These structural changes are associated with an increase in collagen and a corresponding decrease in elastin content [28] . In particular, collagen tends to accumulate in 'gaps' interposed between two adjacent lamellar units. Ultrastructural studies have demonstrated that with age aortic elastin changes its structure and appears as 'encrusted' with an insoluble, collagenase-resistant, fibrillar protein [29] .
Advancing age, independent of other risk factors, leads to important biochemical, histological and structural vascular alterations that determine a proatherogenic environment upon which major cardiovascular risk factors act to favour the progression and destabilization of an atherosclerotic stable plaque. Accordingly, plaque stability is influenced not only by systemic factors, that is, the 'major' atherosclerotic risk factors (cigarette smoking, hypertension, high serum cholesterol and its fractions, low levels of HDL and diabetes mellitus), but also by local factors such as modifications of the arterial wall inducing progression from stable to unstable plaque. Accordingly, ageing influences the local inflammatory response and the histological plaque composition; the unstable plaque is characterized by an active chronic inflammation different from that observed in stable lesions [5, 30, 31] . Unlike in the slow progression phases, macrophages and T cells become activated in vulnerable plaques, producing inflammatory cytokines and lytic enzymes, that is, metalloproteases, which predispose towards the rupture of the plaque itself by digesting and reducing the thickness of the fibrous cap [31, 32] . The Th1 subpopulation of T cells is detected in the plaque, and affects its stability though macrophage activation, SMC growth and extracellular matrix synthesis [31] . The balance between inflammatory and antiinflammatory activity is influenced by the recruitment of the inflammatory cells as well as the haemodynamic stress that favours the expression of adhesion molecules by cytokines produced in the plaque; moreover, several molecules produced during lipid peroxidation are able to stimulate both the [7] and L opez-Ot ın et al. [6] .
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inflammatory processes and the defensive reactions, binding to nuclear receptors regulating genes involved in the inflammation [5, 31] .
Endothelial dysfunction and ageing: the role of nitric oxide in inflammation
The endothelium is important in maintaining vascular homoeostasis and is involved in many physiological functions including regulation of blood pressure, promotion of angiogenesis and control of the coagulation process [33] [34] [35] . The function and health of the vascular network are regulated by the vascular endothelium releasing molecules that act in an autocrine and paracrine manner [36] . In addition to the redox balance [37] [38] [39] [40] [41] [42] , nitric oxide (NO) is the most important mediator of normal endothelial function, through its powerful vasodilator action. NO is synthesized by the endothelial NO synthase (eNOS or NOS III) via the action of different neurohumoral mediators such as acetylcholine and circulating hormones [43] [44] [45] [46] [47] [48] . Reduction in the bioavailability or increased degradation of NO is markers of endothelial dysfunction associated with impaired endothelium-dependent dilatation (EDD), which predicts future cardiovascular events [49] . Hence, a healthy vascular endothelium depends on the balance between pro and antioxidants, vasodilators and vasoconstrictors, pro and antiinflammatory molecules and pro and antithrombotic signals. Endothelial dysfunction occurs when this balance is perturbed inducing pro-oxidant, vasoconstrictor, proinflammatory and prothrombotic effects [25, 50, 51] .
Ageing represents the strongest independent correlate of EDD, as demonstrated by the Framingham Heart Study [52] . Elderly men and women also showed endothelial dysfunction in the absence of clinical disease. Several studies have demonstrated that oxidative stress and inflammation are the most important pathological processes that determine endothelial dysfunction in healthy older adults and in rodent models [53] [54] [55] . Elevated blood pressure, blood glucose, obesity, LDL cholesterol and sodium intake can modulate endothelial dysfunction via both oxidative stress and inflammation in advanced ageing [50, [56] [57] [58] [59] . As demonstrated in studies in several experimental animals and humans, the age-related reduction in EDD is due to the reduced vascular NO bioavailability caused by reduced expression of eNOS and its downstream effects [60, 61] (see Fig. 3 ). However, the precise mechanism underlying the ageassociated decrease in NO remains unclear [33] . Some evidence indicates that prostanoid vasodilators such as prostacyclin are also reduced with age, whilst the reduction of NO induces vasoconstriction mediated by endothelin 1 (ET-1) [33] . NO also reacts with tyrosine, resulting in the formation of nitrotyrosine, which is increased in abundance in aged arteries [62, 63] . During oxidative stress, the elevated reactive oxygen species (ROS) and in particular superoxide anion react with NO resulting in the production of peroxynitrite (ONOOÀ), a very reactive and toxic product [64, 65] (see Fig. 4 ). Indeed, peroxynitrite further inactivates any nearby protein in an irreversible manner in ageing endothelial cells. At the molecular level, NO can induce the S-nitrosylation of reactive cysteines [66] , resulting in the regulation or inactivation of clotting factor XII [67] , AP-1 and CD95L [68] , transglutaminases [69] or mitochondrial adenine nucleotide translocator [70] . This redox-based signalling mechanism regulates the switch between apoptosis and necrosis [61, 71, 72] Arterial ageing / M. Tesauro et al.
role in endothelial dysfunction. Indeed, changes in eNOS regulatory proteins such as caveolin-1, pAkt and heat shock protein 90 contribute to the decreased activity of eNOS in aged endothelial cells. All these alterations are involved in the decrease in both eNOS expression and NO levels in aged endothelial cells [73] . Evidence of oxidative stressassociated suppression of NO and EDD in old arteries is supported by the supply of antioxidants such as superoxide dismutase and vitamin C that improve NO bioavailability and endothelial function in older humans and animals. The decreased expression of eNOS is also due partly to L-arginine degradation by arginase II, with its expression increasing in advanced age [50] .
One of the results of such dysregulation is that the plasma concentrations of inflammatory proteins can increase with age in healthy individuals [74, 75] , including proinflammatory cytokines such as interleukin (IL)-6, tumour necrosis factor alpha (TNF-a) and monocyte chemoattractant protein-1 (MCP-1) [76] . Therefore, their upregulation in advanced ageing underlies a low-grade, chronic, systemic proinflammatory state correlated with age-associated diseases such as diabetes and obesity [77] . Such proinflammatory condition is contingent on nuclear factor-kappa B (NFjB) signalling in endothelial dysfunction, which both reduces cytokine levels and enhances EDD [78] . Indeed, IjB kinase beta is activated in response to inflammatory stimuli or ROS, and then phosphorylates IjB-a, releasing its inhibition and permitting NFjB to translocate into the nucleus where it can activate gene transcription of proinflammatory cytokines. In brief, endothelial cell senescence seems to be associated with increased oxidative stress and inflammation [79, 80] . This inflammation associated with old age is defined as senescence-associated secretory phenotype.
Age-related vascular SMC changes
With age, vascular SMCs undergo functional changes that alter the normal structure of the vessel wall predisposing it to the development of atherosclerosis. From the second decade of life, intimal thickening (IT) develops as an adaptive response to forces acting on the arterial wall [4, [81] [82] [83] . Such thickening comprises various layers of SMCs separated by thin elastic fibres and collagen. Typically IT has a widespread and concentric development in the aorta, whilst appearing eccentric in the coronary arteries. Small plasma-like deposits of alcianophilic material, corresponding to glycosaminoglycans, can be observed within the thickened intima. Electron microscopy has shown that such material consists of granules with an irregular shape associated with thin filaments that appear in connection with the cell membranes of endothelial cells and SMCs [84] . IT has been demonstrated to represent a preatherosclerotic lesion because there is a topographic correspondence between the localisation of IT and the presence of atherosclerotic plaques [85] . The increased permeability observed during IT, evidenced by the presence in the subendothelial space of cholesterol and phospholipids as early as the third decade of life [4] , could be the substrate on which low-level atherosclerotic stimuli (mild hypercholesterolaemia and/or mild hypertension) can promote the development of advanced atherosclerotic lesions. In fact, aged rabbits, as compared to young animals, showed more severe atherosclerotic lesions when fed a long-term hyperlipaemic diet containing a low dose of cholesterol [85, 86] . 
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Fig. 4 Signalling versus toxic effects of peroxynitrate (ONOOÀ). Nitric oxide (NO) is able to react with distinct chemical residues in reversible or irreversible reactions.
Depending on the concentration and chemicophysical microenvironment these reactions could be simplified as a progressive scale of modification. Stamleret and colleagues [45, 46, 71] proposed that whilst reversible reactions are related to signalling, and therefore to the life of the cell, irreversible reactions result in toxic effects. Simplified progression of these chemical mechanisms is shown, in response to nitrosant or oxidant stresses, with their biological effects. Modified from Nicotera and Melino [61] , Stamleret and Hausladen [64] and Hess et al. [65] .
The increased susceptibility to atherosclerosis observed with age is also related to changes in the mechanisms that regulate vascular SMC proliferation, that is, the synthesis and release of various growth factors [87] [88] [89] . Moreover, Stemerman et al. [90] demonstrated that after removal of aortic endothelium vascular SMCs incorporate more 3 H-thymidine in older rats compared to younger animals. SMCs cultured from aged rats showed a higher proliferative rate than cells from young rats, associated with a higher increase in a-SM actin protein levels and mRNA expression. This has been correlated with increased platelet-derived growth factor-like and reduced heparin-like activity [89] . By contrast, Orlandi et al. [91] and McCaffrey and Falcone [92] demonstrated an age-related modification of the antiproliferative response to transforming growth factor beta 1 (TGFb-1) in vascular SMCs that failed to respond to the autocrine growth inhibitory effects of this factor, leading to increased proliferation.
Local environmental factors determine in adult vascular SMCs reversible changes in their phenotype, from 'contractile' to 'synthetic' [88, 93] . The phenotypic modulation often includes all mesenchymal lineages, that is, osteoblasts, chondrocytes and adipocytes. Deregulated signalling of the TGF-b superfamily has been involved in these changes [93] .
Such age-related modifications of the cytoskeleton of SMCs probably determine a remodelling of the arterial wall [94] . With ageing, vascular SMCs also showed modification of the production of NO under specific stimulation [95] [96] [97] . Stimulation with interferon-gamma (IFN-c) plus lipopolysaccharide or IL-1 does not cause a significant production of NO by SMCs of newborn rats, whereas SMCs from old rats present markedly enhanced inducible NOS (iNOS) activity [98] . Similarly in aged SMCs, greater expression of ICAM-1 in response to cytokines and higher production of angiotensinogen has been observed [95, 99] . It is likely that this increase in local angiotensin system activity contributes to the regulation of vascular tone [99] .
Shear stress and ageing
The development of the atherosclerotic plaque is also influenced by the presence of mechanical forces that are exerted on the vessel wall (radial, circumferential and longitudinal forces) or on the endothelial surface (shear stress). Mechanical forces regulate the cellular and molecular composition of plaques [100] , as well as plaque growth [101] . In particular, there is a reduction of endothelial shear stress with ageing, with subsequent development of atherosclerotic plaques [101] .
Shear stress influences endothelial cell inflammatory responses [100] . High shear stress favours the maintenance of the physiological properties of the endothelial barrier (anticoagulant, anti-inflammatory and antioxidant properties). By contrast, low shear causes endothelial cell death and increased platelet and macrophage adhesion to the arterial wall favouring the formation of atherosclerotic plaques through multiple mechanisms that target the MAPK and NFjB pathways [102, 103] . These effects are probably modulated by the expression of specific noncoding RNAs as well as mRNAs in endothelial cells [9, 104, 105] . Shear stress can also influence endothelial cell injury by inducing signalling pathways that regulate apoptosis [100] .
Plaque morphology and ageing
Relatively little is known about changes in carotid plaque morphology during ageing and the possible impact on cardiovascular events. Few studies have so far addressed age-related modifications within atherosclerotic lesions. It seems that comparison between studies is difficult because patient populations are not uniform, distribution of age-related groups differ and various cut-off values have been used to define the elderly population studied. Histological changes in the atherosclerotic plaque with age have been studied mainly in the carotid arteries [106] [107] [108] [109] [110] [111] , because the study of the coronary arteries is possible only on autopsy series (see Fig. 5 ).
Our research group performed the first histological study evaluating the changes in histological composition of carotid plaques with ageing in humans [106] . Carotid plaques from 180 patients with neurological symptoms were divided into three subgroups: patients aged <50 years, 51-70 years and >70 years. Multivariate discriminant analysis has demonstrated that the plaques from older age groups were larger than those from younger subjects. Moreover, aged plaques were stenotic and composed of a large amount of connective tissue associated with newly formed vessels and few or no giant cells. The presence of inflammatory cells was Arterial ageing / M. Tesauro et al.
not evaluated in this study. van Oostrom et al. [107] , in a study of 383 carotid endarterectomy (CEA) samples, observed a decrease of fibrous plaques and an increase of atheromatous plaques with ageing. These changes were accompanied by an age-associated decrease in SMC content in carotid plaques, whereas macrophage content and MMP-9 slightly increased with age. van Lammeren et al. [110] investigated whether the increased risk of stroke in elderly subjects was correlated with plaque morphological changes, and found a decrease in plaque stability with age. Older patients with carotid stenosis showed more unstable plaques characterized by low SMC content, larger lipid cores and more calcification as compared with younger patients.
Similarly Redgrave et al. [109] , investigating a large series of histological symptomatic carotid plaques (526 patients undergoing CEA), also found an increase in plaque calcification and lipid core dimensions paralleled by a decrease in fibrous tissue with age. These morphological changes were associated with reduced overall plaque inflammation. Partially conflicting results were reported by Grufman et al. [111] in a study of 200 plaques from symptomatic and asymptomatic patients undergoing CEA divided into two age groups (<70 and ≥70 years of age). The content of macrophages and lipids was significantly higher in the carotid plaques from symptomatic compared with asymptomatic patients in the elderly group, but not in the younger patients. However, some inflammatory markers, such as IFN-c, TNF-a, soluble CD40 ligand and fractalkine, were significantly decreased in atherosclerotic lesions from these older individuals. The authors concluded that increased plaque vulnerability in the symptomatic elderly patients was associated with the accumulation of lipid components and impaired tissue repair, rather than with inflammatory processes.
These morphological observations are partially inconsistent with experimental data in healthy elderly persons showing that ageing is related to an increased proinflammatory status [112] . A primary feature of the ageing process, as discussed above, is a chronic progressive increase in the proinflammatory status, which was originally termed 'inflamm-ageing' [113] .The cause of the increased proinflammatory status is related to elevated circulating levels of proinflammatory cytokines including IL-1, IL-6, TNF-a and PGE2, which have a major role in pathology [114] [115] [116] [117] [118] [119] . The increased plaque vulnerability in elderly patients is probably correlated with several mechanisms (some of which are linked to the release of inflammatory cytokines), such as endothelial adhesion of inflammatory cells, increased absorption of atherogenic lipoprotein, increase in the necrotic lipid core and calcification of plaque.
Ageing and vascular calcification
Large-scale studies including the Multi-Ethnic Study of Atherosclerosis [120, 121] , the St. Francis Heart Study [122] and the study of Tota-Maharaj et al. [123] in 1015 consecutive asymptomatic South Korean subjects have demonstrated that coronary atherosclerotic calcification increases with age (see Fig. 5 ). Other studies also demonstrated the presence of increased calcification with ageing in the carotid region [124, 125] . Studies in the coronary arteries suggest a role of calcification on plaque instability. There is a strong relationship between mortality and total coronary artery calcium score evaluated by cardiac computed tomography. The coronary artery calcium score has a well-established correlation with coronary plaque burden, with higher score values being associated with increased risk of adverse cardiovascular outcomes [25, 121, 126, 127] . Nevertheless, coronary calcification, as we have also shown [128] , can be considered as an indirect plaque vulnerability factor, because coronary artery calcium score does not predict the segment that will undergo rupture but identifies vulnerable patients at risk of fatal cardiac events. In particular, the presence of large amounts of calcifications in a severely stenotic coronary segment should contribute to the rupture of a vulnerable lesion in a less stenotic adjacent segment, as observed in our cases, inducing changes in mechanical properties and shear stress of the arterial wall [128] .
Two different types of calcific vasculopathy, inflammatory and metabolic, have been hypothesized by Demer and Tintut [129] . The former is associated with calcification of a necrotic lipid core that occurs in aged atherosclerotic plaques, and the latter is correlated with chronic kidney disease and calcification of the tunica media. Although in the past the plaque calcification process was considered as an unregulated and dystrophic event, in recent years some evidence has demonstrated that the presence of calcification is characterized by an active process [129, 130] . Indeed, the calcification process in atherosclerotic lesions appears to be associated with lipid oxidation, endothelial damage and the secondary inflammatory response [130] , changes that are all associated with vascular ageing. The formation of microcalcifications can be mediated by cell death and release of apoptotic bodies in these areas. These apoptotic bodies are similar to vesicles found in the bone matrix, which contain the components required for the deposition of calcium crystals (including calcium and inorganic phosphate ions) and which facilitate the formation of needle-shaped crystals of hydroxyapatite [131] .
Conclusion
Ageing is the most powerful atherosclerotic risk factor, which explains why the incidence and prevalence of cardiovascular disease tend to increase with chronological as well as biological ageing. Vascular ageing can no longer be considered as an immutable and inexorable process, but rather as a target of possible interventions aimed at achieving a healthier vascular ageing. The aged artery is characterized by endothelial dysfunction, chronic inflammation, oxidative stress, migration and proliferation of vascular SMCs and arterial calcification. Lifestyle modifications including healthy eating patterns, physical activity and weight management showed positive effects on reducing cardiovascular disease risk in patients with atherosclerosis. The molecular mechanisms underlying arterial ageing could be putative candidates for targeting by interventions to prevent and slow the ageing of arteries as a major risk factor for cardiovascular disease.
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